Abstract-The endothelial cytoskeleton plays a key role in arterial responses to acute changes in shear stress. We evaluated whether the intermediate filament protein vimentin is involved in the structural responses of arteries to chronic changes in blood flow (BF). In wild-type mice (Vϩ/ϩ) and in vimentin-deficient mice (VϪ/Ϫ), the left common carotid artery (LCA) was ligated near its bifurcation, and 4 weeks later, the structures of the occluded and of the contralateral arteries were evaluated and compared with the structures of arteries from sham-operated mice. 3 m 2 for LCA and RCA, respectively). In Vϩ/ϩ, LCA ligation eliminated BF in the occluded vessel (before ligation, 0.35Ϯ0.02 mL/min) and increased BF from 0.34Ϯ0.02 to 0.68Ϯ0.04 mL/min in the RCA. In VϪ/Ϫ, the BF change in the occluded LCA was comparable (from 0.38Ϯ0.05 mL/min to zero-flow rates), but the BF increase in the RCA was less pronounced (from 0.33Ϯ0.02 to 0.50Ϯ0.05 mL/min). In the occluded LCA of Vϩ/ϩ, arterial diameter was markedly reduced (Ϫ162 m), and CSAm was significantly increased (5ϫ10 3 m 2 ), whereas in the high-flow RCA of Vϩ/ϩ, carotid artery diameter and CSAm were not significantly modified. In the occluded LCA of VϪ/Ϫ, arterial diameter was reduced to a lesser extent (Ϫ77 m) and CSAm was increased to a larger extent (10ϫ10 3 m 2 ) than in Vϩ/ϩ. In contrast to Vϩ/ϩ, the high-flow RCA of VϪ/Ϫ displayed a significant increase in diameter (52 m) and a significant increase in CSAm (5ϫ10 3 m 2 ). These observations provide the first direct evidence for a role of the cytoskeleton in flow-induced arterial remodeling.
Rationale: Hypertension is a major risk factor for cerebral small vessel disease, the most prevalent cause of vascular cognitive impairment. As we have shown, hypertension induced by a prolonged Angiotensin II infusion is associated with increased permeability of the blood-brain barrier (BBB), chronic activation of microglia and myelin loss. In this study we therefore aim to determine the contribution of microglia to hypertension-induced cognitive impairment in an experimental hypertension model by a pharmacological depletion approach. Methods: For this study, adult Cx3Cr1 gfp/wt x Thy1 yfp/0 reporter mice were infused for 12 weeks with Angiotensin II or saline and subgroups were treated with PLX5622, a highly selective CSF1R tyrosine kinase inhibitor. Systolic blood pressure (SBP) was measured via tail-cuff. Short- and long-term spatial memory was assessed during an Object Location task and a Morris Water Maze task (MWM). Microglia depletion efficacy was assessed by flow cytometry and immunohistochemistry. BBB leakages, microglia phenotype and myelin integrity were assessed by immunohistochemistry. Results: SBP, heart weight and carotid pulsatility were increased by Ang II and were not affected by PLX5622. Short-term memory was significantly impaired in Ang II hypertensive mice, and partly prevented in Ang II mice treated with PLX5622. Histological and flow cytometry analysis revealed almost complete ablation of microglia and a 60% depletion of brain resident perivascular macrophages upon CSF1R inhibition. Number and size of BBB leakages were increased in Ang II hypertensive mice, but not altered by PLX5622 treatment. Microglia acquired a pro-inflammatory phenotype at the site of BBB leakages in both Saline and Ang II mice and were successfully depleted by PLX5622. There was however no significant change in myelin integrity at the site of leakages. Conclusion: Our results show that depletion of microglia and PVMs, by CSF1R inhibition prevents short-term memory impairment in Ang II induced hypertensive mice. We suggest this beneficial effect is mediated by the major decrease of pro-inflammatory microglia within BBB leakages. This novel finding supports the critical role of brain immune cells in the pathogenesis of hypertension-related cognitive impairment. An adequate modulation of microglia /PVM density and phenotype may constitute a relevant approach to prevent and/or limit the progression of vascular cognitive impairment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.